Sulfonylurea for improving neurological features in neonatal diabetes: A systematic review and meta-analyses.
Caroline de Gouveia Buff PassoneElisa GianiLaurence Vaivre-DouretDulanjalee KariyawasamMarianne BerdugoLaure GarcinJacques BeltrandWanderley Marques BernardoMichel PolakPublished in: Pediatric diabetes (2022)
Glibenclamide significantly improved neurological abnormalities in patients with neonatal-onset diabetes due to KCNJ11 or ABCC8 mutations. Hypotonia was the symptom that responded best. Earlier treatment initiation was associated with greater benefits.